Immunotherapy Clinical Trials in Nanjing, Jiangsu
6 recruitingNanjing, Jiangsu, China
Showing 1–6 of 6 trials
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
Robotic SurgeryStage IIB-III NSCLCNeoadjuvant Chemoimmunotherapy+1 more
Shanghai Chest Hospital100 enrolled10 locationsNCT07541521
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
Stage IIB-III NSCLCNeoadjuvant ChemoimmunotherapyRobotic Pulmonary Resection
Shanghai Chest Hospital200 enrolled10 locationsNCT07528066
Recruiting
Phase 3
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Esophagus CancerChemotherapy EffectTargeted Therapy+3 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2,000 enrolled5 locationsNCT04821778
Recruiting
Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study
ImmunotherapyUnresectable Biliary Tract CancerDynamic Prediction Model
Zhongda Hospital332 enrolled2 locationsNCT06849193
Recruiting
Phase 3
Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma
Hepatocellular CarcinomaImmunotherapyPreoperative
The First Affiliated Hospital with Nanjing Medical University130 enrolled1 locationNCT05613478
Recruiting
Immunotherapy for Hepatocellular Carcinoma
Hepatocellular CarcinomaImmunotherapy
The First Affiliated Hospital with Nanjing Medical University11,000 enrolled1 locationNCT06241326